Profilo
Carl Walkey is the founder of Ansible Marketing, Inc. (founded in 2014) and Neoleukin Therapeutics, Inc. (founded in 2003).
At Neoleukin Therapeutics, he held the title of Senior Vice President-Corporate Development from 2021 to 2022.
Dr. Walkey earned a doctorate degree from the University of Toronto.
Precedenti posizioni note di Carl Walkey
Società | Posizione | Fine |
---|---|---|
NEUROGENE INC. | Founder | 01/12/2022 |
Ansible Marketing, Inc. | Founder | - |
Formazione di Carl Walkey
University of Toronto | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Neoleukin Therapeutics, Inc.
Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
Ansible Marketing, Inc. |
- Borsa valori
- Insiders
- Carl Walkey